Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases.

Angelika M StarzerAriane SteindlMaximilian J MairCarola DeischingerAnika SimonovskaGeorg WidhalmBrigitte GatterbauerKarin DieckmannGerwin HellerMatthias PreusserAnna Sophie Berghoff

Published in: British journal of cancer (2021)

Systemic inflammation, measured by NLR, LLR, PLR, MLR and CRP/Alb, was associated with OS in patients with BM. Further exploration of immune modulating therapies is warranted in the setting of BM.

Keyphrases

brain metastases
newly diagnosed
small cell lung cancer
signaling pathway
free survival